Conversations from ESMO Targeted Anticancer Therapies Congress 2024
Drug Discovery World
MARCH 26, 2024
For example, progress made in developing gene mutant-specific inhibitors, antibody-drug conjugates (ADC), or cellular therapies. OR: The presentations at ESMO TAT 2024 highlighted our advances in targeted and more personalised anti-tumour therapies. MT: What data did you present at the conference?
Let's personalize your content